Prometheon touts its transdermal delivery system for large molecules, prepares to launch hair growth gel

Prometheon Pharma says it has developed a breakthrough transdermal drug delivery system that can passively deliver large molecules like human growth hormone (which has a size of 2,200 daltons) across the skin. It just announced that it is preparing to launch a cosmetic hair growth gel for transdermal delivery of IGF-1 in the second half of the year. Prometheon is exploring other uses of its transdermal delivery system, especially in diabetes care. The company told FierceDrugDelivery that is actively seeking a Big Pharma partner to deploy its clinical-stage patch for transdermal delivery of insulin. Release

Suggested Articles

J&J figures its partner Genmab owes a share of Darzalex Faspro royalties to Halozyme for its subcutaneous delivery tech. Genmab doesn't agree.

Bexson Biomedical and Stevanato Group teamed up to develop a ketamine pump that may help patients better manage pain at home.

Australia's University of New South Wales and Uka Tarsadia University in India will join forces to explore contact lenses for ocular drug delivery.